PCI Biotech: Invitation to second quarter and first half 2019 results presentation


Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park.

Time: Wednesday 28 August, 08:30am – 09:30am CEST (local time).
Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo.

The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to

The presentation will also be a live webcast and can be accessed through It will be possible to post questions through the webcast console.

The interim report and the presentation will be available on and on the company's webpage, from 07:00am (CEST) on 28 August 2019.

For further information, please contact:

Ronny Skuggedal, CFO
Mobile: +47 9400 5757

About PCI Biotech         
PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform.  PCI is applied to three distinct anticancer paradigms: fimaChem (enhancement of chemotherapeutics for localised treatment of cancer), fimaVacc (T-cell induction technology for therapeutic vaccination), and fimaNAc (nucleic acid therapeutics delivery).

Photochemical internalisation induces triggered endosomal release that is used to unlock the true potential of a wide array of therapeutic modalities. The company’s lead programme fimaChem consists of a pivotal study in bile duct cancer, an orphan indication with a high unmet need and without approved products. fimaVacc applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines, which works in synergy with several other state-of-the-art vaccination technologies. fimaNAc utilises the endosomal release to provide intracellular delivery of nucleic acids, such as mRNA and RNAi therapeutics, thereby addressing one of the major bottlenecks facing this emerging and promising field.

For further information, please visit:                       
Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo                

Forward-looking statements    
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements. PCI Biotech disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ASMI Share Buyback Update September 14 – 18, 202021.9.2020 17:45:00 CESTPress release

Almere, The Netherlands September 21, 2020, 5:45 p.m. CET ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI's current share buyback program. DateRepurchased sharesAverage priceRepurchased valueSeptember 14, 2020---September 15, 2020---September 16, 20206,000€ 122.37€ 734,241September 17, 202015,000€ 117.84€ 1,767,600September 18, 202025,000€ 119.53€ 2,988,128Total46,000€ 119.35€ 5,489,969 These repurchases were made as part of the €100 million share buyback program announced on June 2, 2020. Of the total program, 32.6% has been repurchased. For further details including individual transaction information please visit: About ASM International ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participation

EVS Broadcast Equipment reports update of share buyback program21.9.2020 17:45:00 CESTPress release

Publication on September 21, 2020, after market closing Regulated information – reporting share buyback EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS reports update of share buyback program EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on May 6, 2020, took place between September 14, 2020 and September 18, 2020. DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)14/09/20204,04014.895615.1214.58 60,178 15/09/20204,97414.683414.8014.60 73,035 16/09/20205,12314.546714.9814.30 74,523 17/09/20205,50014.481814.8814.20 79,650 18/09/20205,95014.122714.3413.86 84,030 Total25,587 14.5158 15.12 13.86 371,416 As of September 18, 2020, and since the start of the buyback program, EVS has bought 231,649 shares at an average price of EUR 15,4224, representing in total EUR 3,572,576. After aforementioned transactions

Completion of vessel sale21.9.2020 17:12:01 CESTPress release

Bermuda, 21 September 2020 - Avance Gas Holding Ltd (OSE: AVANCE) refer to the press release dated 4 August 2020, the transaction for the sale of the 2003-built VLGC Avance was successfully completed today. Following repayment of debt, the transaction will generate approx. $17 million in net cash proceeds, with a book profit of approx. $6 million to be recorded in the third quarter. The sale follows the company’s fleet renewal strategy, reducing average age and improving the fuel efficiency of the overall fleet which was also complemented by the contracting of two 91,000 cbm LPG dual fuel newbuilding’s to be delivered in 2021/2022. For further queries, please contact: Randi Navdal Bekkelund, CFO Tel: +47 22 00 48 29 About Avance Gas Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carrier (VLGC), and operates a fleet of thirteen modern ships and two Dual Fuel LP

Real People Investment Holdings Limited: Results from the written procedure initiated on 9 September 202021.9.2020 17:00:00 CESTPress release

Real People Investment Holdings Limited's ("RPIH") requests to approve amendments to the terms and conditions of its SEK and NOK bonds have been approved. On 9 September 2020, RPIH instructed Nordic Trustee & Agency AB (publ) (the "Agent") to initiate a written procedure for RPIH's up to SEK 260,000,000 and NOK 135,000,000 senior unsecured callable bonds with ISIN SE0005392560 and NO0010689342 (the "Bonds") in order to request (the "Requests") that the bondholders agree to that, inter alia: the final maturity date shall be extended to 31 March 2028; the scheduled specified amortisations shall be replaced by a minimum repayment undertaking pursuant to which RPIH shall ensure that the Capital Nominal Amount (as defined in the Terms and Conditions) does not exceed: 92 percent. of the Initial Capital Nominal Amount (as defined in Schedule 3 (Amended and Restated Terms and Conditions) in the notice of written procedure) on 31 March 2023;77 percent. of the Initial Capital Nominal Amount on 3

Organisational changes and ESG investor seminar21.9.2020 16:30:00 CESTPress release

Oslo, 21 September 2020: Yara makes organisational changes effective 1 October, and announces an ESG investor seminar to be held 3 December 2020. “The organisational changes we make today support Yara’s ongoing transition towards providing sustainable solutions for the global food system, and we look forward to presenting the next steps in our transition during our ESG investor seminar later this year,” said Svein Tore Holsether, President & CEO. Lair Hanzen, currently EVP Yara Americas, is appointed Special Advisor to the President & CEO, reporting to Svein Tore Holsether and relocating to Oslo. Hanzen will support Yara’s ongoing activities within green ammonia, building on our leading position in ammonia production technology and distribution, and will in this capacity report to EVP Farming Solutions Terje Knutsen. Hanzen will also initiate a review of Yara’s asset base in the context of the ongoing transition, initially focusing on Yara’s mining projects. Chrystel Monthean, currentl


Complete terms and conditions can be retrieved at Bid procedure on 23 September 2020 Certificate:Commercial paper issued in SEK by non-financial companies with a registered office in Sweden and with a remaining maturity of up to six months on the Bid date, i.e. with the maturity date on 23 March 2021 at the latest. Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 14 September 2020.Bids:Counterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to date:Wednesday 23 September 2020Bid time:0900-0930 hours (CEST) on the Bid dateRequested volume: (corresponding nominal amount)SEK 4 billion Highest permitted bid volume: (co